INSEAD Day 4 - 728x90

Mashreq Q1 profit rises

Total revenue increased 10% year-on-year.

TECOM profit climbs

High occupancy across assets boosts earnings.

Emirates Stallions Q1 revenue up 11%

The rise helped by strong demand in real estate

ADNOC Distribution 2025 dividend $700m

The company had reported EBITDA of $1.17 bn in 2025.

Empower okays $119.1m H2 2025 dividend

The dividend is equivalent to 43.75% of paid-up capital.

SPIMACO secures $335m loan

Set up in 1986, the pharma company is one of the biggest players in the Saudi medical sector. (SPIMACO)
  • The pharma company secured the shariah-compliant financing to grow the business
  • The firm obtained the facilities in the form of short-term loans to finance working capital needs, long-term loans for expansions and investments, and treasury facilities

Riyadh, Saudi Arabia— Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has obtained a loan of $335 million from Bank Albilad, Gulf International Bank, and Banque Saudi Fransi.

The pharma company secured the shariah-compliant financing to grow the business.

The firm obtained the facilities in the form of short-term loans to finance working capital needs, long-term loans for expansions and investments, and treasury facilities, according to a bourse filing.

Bank Albilad, Gulf International Bank, and Banque Saudi Fransi were the sole financing entities of the transaction.

Established in 1986, SPIMACO is one of the biggest players in the Saudi medical sector, engaged in manufacturing and distributing pharmaceutical products and medical appliances.